Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Deep venous thrombosis (DVT) is the most common complication in patients with traumatic fractures. The neutrophil extracellular traps (NETs) can promote thrombus formation. In this prospective study, we investigated the role of NETs in thrombosis in patients with traumatic fractures to evaluate whether the biomarkers of NETs can be used to help predict the risk of thrombosis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Traumatic fracture patients were enrolled in this prospective observational cohort study. Healthy controls (Control); patients with lower extremity fractures who neither present with nor develop DVT (Trauma non-DVT); patients with lower extremity fractures who do not present with DVT but do develop DVT (Trauma DVT); and patients with lower extremity fractures who present with DVT (DVT) were included. NETs biomarker levels of Citrullinated Histone H3 (H3Cit), cell-free DNA (cfDNA) and nucleosomes in the plasma were determined. The D-dimer and fibrin(-ogen) degradation products (FDP) level in plasma was measured. Statistical analysis of the test results was performed to assess changes in NETs biomarker levels during thrombosis in patients with traumatic fractures.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The H3Cit levels in the DVT group were significantly greater than in the Trauma non-DVT group and Trauma DVT group (1.88(1.11, 3.35) ng/ml Vs 0.38(0.10, 1.17) ng/ml, P≤0.05). The level of cfDNA was significantly greater in patients with traumatic fractures and was higher after thrombosis than before. The levels of D-dimer in the DVT, Trauma DVT, and Trauma non-DVT groups were significantly greater than in the Control group (5.11(3.97, 8.11) mg/l; 6.12(2.59, 18.49) mg/l; 2.99(0.99, 9.02) mg/l Vs 0.18(0.08,0.24) mg/l, P<0.05). The distribution of FDP levels in each group was similar to that of D-dimer. Data are presented as medians (25th percentile, 75th percentile).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>NETs released by neutrophils are involved in the formation of DVTs in patients with traumatic fractures. H3Cit and cfDNA can assist the diagnosis of DVT in patients with traumatic fractures.</p>

The effect of neutrophil extracellular traps in venous thrombosis

[Research progress on neutrophil extracellular traps in tumor].

Impact of Neutrophil Extracellular Traps on Thrombosis Formation: New Findings and Future Perspective

Neutrophil Extracellular Traps in Arterial and Venous Thrombosis

The Role of Neutrophil Extracellular Traps in Central Nervous System Diseases and Prospects for Clinical Application

Effect of neutrophil extracellular traps (NET) on thrombosis: A literature review

Neutrophil Extracellular Traps: Signaling Properties and Disease Relevance

Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy

Neutrophil extracellular traps - an a-list-actor in a variety of diseases

Neutrophil Extracellular Traps and the Effects in Related Diseases

Neutrophil Extracellular Traps and Endothelial Dysfunction in Atherosclerosis and Thrombosis

Rethinking neutrophil extracellular traps

Neutrophil Extracellular Traps Affecting Cardiovascular Health in Infectious and Inflammatory Diseases

The impact of neutrophil extracellular traps on deep venous thrombosis in patients with traumatic fractures

Neutrophil extracellular traps: neutrophil’s afterlife

Composition and Function of Neutrophil Extracellular Traps

Neutrophil extracellular traps: a catalyst for atherosclerosis

Worsening Thrombotic Complication of Atherosclerotic Plaques Due to Neutrophils Extracellular Traps: A Systematic Review

[The Immunomodulatory Effect of Neutrophil Extracellular Trapping Nets (nets) on Hematological Diseases].

Recent Insights into Neutrophil Extracellular Traps in Cardiovascular Diseases

Neutrophil extracellular traps in homeostasis and disease